Clinical relevance of antibiotic-induced endotoxin release.
about
Bacteriophage therapyEndotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shockBovine colostrum in oral treatment of enterogenic endotoxaemia in ratsTreating critical illness: the importance of first doing no harmA Dormant Microbial Component in the Development of PreeclampsiaAntibacterial compounds of Canadian honeys target bacterial cell wall inducing phenotype changes, growth inhibition and cell lysis that resemble action of β-lactam antibioticsInterference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?Granulocyte colony stimulating factor induces lipopolysaccharide (LPS) sensitization via upregulation of LPS binding protein in ratAntibiotic treatment of experimental pneumonic plague in miceUpdate on meningococcal disease with emphasis on pathogenesis and clinical managementModulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coli.Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.Genetically modified bacteriophages in applied microbiology.Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin.Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration.Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem.Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum.Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factorsAntibiotic-induced endotoxin release from bacteria and its clinical significance.Structural correlation between lipophilicity and lipopolysaccharide-sequestering activity in spermine-sulfonamide analogs.In vivo toxicity study of phage lysate in chickens.Structural correlates of antibacterial and membrane-permeabilizing activities in acylpolyamines.Influence of in-vivo endotoxin liberation on anti-anaerobic antimicrobial efficacy.Antiendotoxin activity of antimicrobial peptides and glycopeptides.Antibiotic-induced release of inflammatory mediators from bacteria in experimental Klebsiella pneumoniae-induced sepsis.Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review.Control of endotoxin release in Escherichia coli fed-batch cultures.Release of exotoxin A, peptidoglycan and endotoxin after exposure of clinical Pseudomonas aeruginosa isolates to carbapenems in vitro.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?The role of caspase-3 in lipopolysaccharide-mediated disruption of intestinal epithelial tight junctions.Antibacterial agents that inhibit lipid A biosynthesis.Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus.
P2860
Q24550616-095009A1-FFDA-4CAB-813F-739DDFE5E93BQ24806164-944DBDF9-220F-4614-9684-B11794FD16F8Q24807115-A41A5F15-05F6-4744-BF8D-D6FBC90F89BBQ24813804-5751DEF8-8CEF-4388-B1B4-449EAA48F71DQ28069689-708B2320-0CFD-4DAA-8E2B-CA6227C42BCCQ28542836-829E7C2B-FA89-4A7E-92E8-F07115A414E8Q30327329-D1FE45E0-BC48-464C-A8C0-A03E2899C7C5Q31111690-77B1AF90-F001-4220-A5C5-6C787FD4641CQ33691477-F65512E7-A04B-45F1-9F2C-B319EE9A862FQ33812435-1137149F-2E08-4D88-A5F2-0DBE4D2F2F27Q34487226-E224954A-48CE-4C13-A1DA-D70D63FE3F32Q34529381-21A99DFA-C1F1-4645-949E-9B7B0504B49BQ35121455-9D52EC09-C893-4310-9454-8805FA8144DEQ35542067-D95E287B-B851-4639-B375-ED2497DFECD4Q35590092-9DF966FD-1B0F-4744-A9EA-997CE12B5393Q35765830-CCAB1254-7052-49C5-8F21-8B0A9280C09AQ37670671-35995E6D-6F38-4C25-ABB6-047C2318A86DQ38870317-2FE17BEA-3A9D-4469-B028-BDD995AA00AFQ39472702-77CF530A-861B-40D0-8E6F-F44903FFB09EQ39503515-CEE447EF-52CC-4BBA-A35C-77A28CBB7294Q39783003-221E988F-398F-4A8C-A31E-F883C77D97DCQ39785146-0BE4CB0F-294E-4CCB-9E5C-4180C3900739Q39822209-6114B1BD-7701-41DB-BF74-16A5B3623166Q40496805-3F83DFAD-543C-49DA-AD6D-77481A04EC47Q41477525-FFD9B17B-7A55-402E-90B1-A99D318A1ABEQ41544081-0E3A0E70-3080-4389-AC46-2853FF6DFC67Q43244596-55D88E8D-C301-4C74-B7A4-2A729DE7CBE8Q43260803-516F9201-6D36-4369-99B6-807FD05D10F1Q43835989-A5C660C4-1F53-4D39-BE61-9324B492EBD1Q44471907-6A8D1CC4-88FD-405F-B191-C26D38343879Q44531424-F27FDC9A-FB1E-4969-9510-DFA02AF7C1BDQ45137694-C6748F0E-2D84-45E5-92EF-754BF901D98DQ45172410-AAC29E24-C6A2-4C20-82FE-F97CCE9B7619Q46752236-DB97B549-A587-49E0-80AB-7A6CF4F1FA56Q50016951-C294BDD7-940E-494C-B472-F23B19B0755EQ53577854-9D97179D-1F62-444B-A15E-6B41C3C65843Q54577312-D8BF5B93-DA0D-4DD6-AED4-A900FE0949D6Q55026346-D52B0B8F-A2A8-4D31-9DEA-CCBAFA32D4C6
P2860
Clinical relevance of antibiotic-induced endotoxin release.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Clinical relevance of antibiotic-induced endotoxin release.
@en
Clinical relevance of antibiotic-induced endotoxin release.
@nl
type
label
Clinical relevance of antibiotic-induced endotoxin release.
@en
Clinical relevance of antibiotic-induced endotoxin release.
@nl
prefLabel
Clinical relevance of antibiotic-induced endotoxin release.
@en
Clinical relevance of antibiotic-induced endotoxin release.
@nl
P2093
P2860
P356
P1476
Clinical relevance of antibiotic-induced endotoxin release.
@en
P2093
Kuijper EJ
Speelman P
van Deventer SJ
P2860
P304
P356
10.1128/AAC.38.6.1211
P407
P577
1994-06-01T00:00:00Z